Coronary Artery Revascularization in Diabetes

Stopped early · Phase 4

Conditions studied: Coronary Artery Disease

In brief

This is a randomized, multi-site, clinical trial comparing percutaneous coronary stenting (PCI) with drug eluding stents to coronary bypass for angiographically significant coronary artery disease in diabetes. The hypothesis being tested is that a strategy of surgical revascularization is superior to percutaneous intervention in preventing death or myocardial infarction in diabetics with severe ischemic heart disease.

Key facts

Study ID
NCT00326196
Run by
US Department of Veterans Affairs
People needed
198
Starts
2006-07-01
Expected to finish
2012-08-01
Last updated by the study team
2014-04-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.